Fitzgerald’s depature came less than a full day after Politico revealed she had bought stock in a tobacco company a day after taking her job

Quick Read

Pfizer, one of the world’s largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer’s disease and Parkinson’s disease. The reason? Pfizer believes that research on the two diseases doesn’t make sense financially

Quick Read

Decentralized databases promise to revolutionize medical records, but not until the health-care industry buys in to the idea and gets to work

Quick Read

Although vaccines typically take years to produce, test, and license, US health officials had voiced confidence that Zika would not be a difficult target, and some predicted that a vaccine could be made and fully tested, ready for FDA assessment, within two to three years. Others predicted a licensed Zika vaccine could be available sometime in 2020

Quick Read

Hub aims to make industrial-scale high-resolution brain mapping a standard tool for neuroscience

Quick Read

Research university leaders see wake-up call in data on sharp partisan divide on higher education, and deep cuts proposed by Trump

Quick Read

Major investment in regenerative medicine enters its last stage — and the money might run out before treatments are ready

Quick Read

Deals continue to be signed for gene-editing tool called Crispr-Cas9

Quick Read